{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:19:48Z","timestamp":1792430388597,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74412-2","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:08:10Z","timestamp":1781608090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The bacteroidal metabolite O-LysoPE facilitates hepatocyte-mediated immunosuppression in autoimmune hepatitis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9800-5198","authenticated-orcid":false,"given":"Mengyi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangkang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8632-6313","authenticated-orcid":false,"given":"Junjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1654","authenticated-orcid":false,"given":"Chuanlong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-9855","authenticated-orcid":false,"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-6883","authenticated-orcid":false,"given":"Hongwei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2260-035X","authenticated-orcid":false,"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"74412_CR1","first-page":"e070201","volume":"380","author":"L Muratori","year":"2023","unstructured":"Muratori, L., Lohse, A. W. & Lenzi, M. Diagnosis and management of autoimmune hepatitis. BMJ Clin. Res. 380, e070201 (2023).","journal-title":"BMJ Clin. Res."},{"key":"74412_CR2","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: autoimmune hepatitis. J. Hepatol. 63, 971\u20131004 (2015).","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"74412_CR3","doi-asserted-by":"crossref","unstructured":"Mack, C. L. et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72, 671\u2013722 (2020).","DOI":"10.1002\/hep.31065"},{"key":"74412_CR4","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.cgh.2017.06.001","volume":"15","author":"C Efe","year":"2017","unstructured":"Efe, C. et al. Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 15, 1950\u20131956 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"74412_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani, G. et al. Autoimmune hepatitis. Nat. Rev. Dis. Primers 4, 18017 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"74412_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","volume":"73","author":"AW Lohse","year":"2020","unstructured":"Lohse, A. W. et al. Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. J. Hepatol. 73, 1496\u20131506 (2020).","journal-title":"J. Hepatol."},{"key":"74412_CR7","doi-asserted-by":"crossref","unstructured":"Reau, N. S., Lammert, C. S. & Weinberg, E. M. Autoimmune hepatitis: current and future therapies. Hepatol. Commun. 8, e0458 (2024).","DOI":"10.1097\/HC9.0000000000000458"},{"key":"74412_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","volume":"19","author":"B Terziroli Beretta-Piccoli","year":"2022","unstructured":"Terziroli Beretta-Piccoli, B., Mieli-Vergani, G. & Vergani, D. Autoimmmune hepatitis. Cell Mol. Immunol. 19, 158\u2013176 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"74412_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1053\/j.gastro.2008.05.078","volume":"135","author":"LE Holz","year":"2008","unstructured":"Holz, L. E. et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 135, 989\u2013997 (2008).","journal-title":"Gastroenterology"},{"key":"74412_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1172\/JCI200421593","volume":"114","author":"DG Bowen","year":"2004","unstructured":"Bowen, D. G. et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J. Clin. Investig. 114, 701\u2013712 (2004).","journal-title":"J. Clin. Investig."},{"key":"74412_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO;2-F","volume":"28","author":"P Bertolino","year":"1998","unstructured":"Bertolino, P., Trescol-Bi\u00e9mont, M. C. & Rabourdin-Combe, C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur. J. Immunol. 28, 221\u2013236 (1998).","journal-title":"Eur. J. Immunol."},{"key":"74412_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","volume":"10","author":"AW Thomson","year":"2010","unstructured":"Thomson, A. W. & Knolle, P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10, 753\u2013766 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"74412_CR13","first-page":"3403","volume":"118","author":"S L\u00fcth","year":"2008","unstructured":"L\u00fcth, S. et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J. Clin. Investig. 118, 3403\u20133410 (2008).","journal-title":"J. Clin. Investig."},{"key":"74412_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0023677215572841","volume":"49","author":"F Heymann","year":"2015","unstructured":"Heymann, F., Hamesch, K., Weiskirchen, R. & Tacke, F. The concanavalin A model of acute hepatitis in mice. Lab. Anim. 49, 12\u201320 (2015).","journal-title":"Lab. Anim."},{"key":"74412_CR15","doi-asserted-by":"publisher","first-page":"575572","DOI":"10.3389\/fimmu.2020.575572","volume":"11","author":"H Wang","year":"2020","unstructured":"Wang, H., Feng, X., Yan, W. & Tian, D. Regulatory T cells in autoimmune hepatitis: unveiling their roles in mouse models and patients. Front. Immunol. 11, 575572 (2020).","journal-title":"Front. Immunol."},{"key":"74412_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-02180-3","volume":"18","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model. J. Transl. Med. 18, 3 (2020).","journal-title":"J. Transl. Med."},{"key":"74412_CR17","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. Serum amyloid A1-induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression. Hepatology. 83, 1049\u20131065 (2026).","DOI":"10.1097\/HEP.0000000000001419"},{"key":"74412_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","volume":"205","author":"M Holdener","year":"2008","unstructured":"Holdener, M. et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J. Exp. Med. 205, 1409\u20131422 (2008).","journal-title":"J. Exp. Med."},{"key":"74412_CR19","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262\u20131267 (2012).","journal-title":"Science"},{"key":"74412_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/embj.201489966","volume":"34","author":"JT Van Praet","year":"2015","unstructured":"Van Praet, J. T. et al. Commensal microbiota influence systemic autoimmune responses. EMBO J. 34, 466\u2013474 (2015).","journal-title":"EMBO J."},{"key":"74412_CR21","doi-asserted-by":"crossref","unstructured":"Xu, M. et al. Role of intestinal microbes in chronic liver diseases. Int. J. Mol. Sci. 23, 12661 (2022).","DOI":"10.3390\/ijms232012661"},{"key":"74412_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113516","volume":"42","author":"J Middelburg","year":"2023","unstructured":"Middelburg, J. et al. The MHC-E peptide ligands for checkpoint CD94\/NKG2A are governed by inflammatory signals, whereas LILRB1\/2 receptors are peptide indifferent. Cell Rep. 42, 113516 (2023).","journal-title":"Cell Rep."},{"key":"74412_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg, H., Adolph, T. E. & Trauner, M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 34, 1700\u20131718 (2022).","journal-title":"Cell Metab."},{"key":"74412_CR24","first-page":"790","volume":"23","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Zhou, Z., Hao, H. & Cao, L. Host-microbe co-metabolism system as potential targets: the promising way for natural medicine to treat atherosclerosis. Chin. J. Nat. Med. 23, 790\u2013800 (2025).","journal-title":"Chin. J. Nat. Med."},{"key":"74412_CR25","first-page":"158","volume":"23","author":"Z Chen","year":"2025","unstructured":"Chen, Z., Zhou, J., Zheng, X., Xie, H. & Hao, H. Metabolic insights into gut microbiota in the pharmacology of natural medicines. Chin. J. Nat. Med. 23, 158\u2013168 (2025).","journal-title":"Chin. J. Nat. Med."},{"key":"74412_CR26","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.cmet.2025.08.005","volume":"37","author":"VR Mu\u00f1oz","year":"2025","unstructured":"Mu\u00f1oz, V. R. et al. Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance. Cell Metab. 37, 2048\u20132065 (2025).","journal-title":"Cell Metab."},{"key":"74412_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","volume":"26","author":"L Lu","year":"2007","unstructured":"Lu, L. et al. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26, 593\u2013604 (2007).","journal-title":"Immunity"},{"key":"74412_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","volume":"391","author":"VM Braud","year":"1998","unstructured":"Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C. Nature 391, 795\u2013799 (1998).","journal-title":"Nature"},{"key":"74412_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10335-5","volume":"10","author":"BI Pereira","year":"2019","unstructured":"Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition. Nat. Commun. 10, 2387 (2019).","journal-title":"Nat. Commun."},{"key":"74412_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","volume":"41","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell 41, 272\u2013287 (2023).","journal-title":"Cancer Cell"},{"key":"74412_CR31","first-page":"1","volume":"51","author":"TS Kim","year":"2019","unstructured":"Kim, T. S. & Shin, E. C. The activation of bystander CD8(+) T cells and their roles in viral infection. Exp. Mol. Med. 51, 1\u20139 (2019).","journal-title":"Exp. Mol. Med."},{"key":"74412_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21737-9","volume":"12","author":"I Santos-Zas","year":"2021","unstructured":"Santos-Zas, I. et al. Cytotoxic CD8(+) T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat. Commun. 12, 1483 (2021).","journal-title":"Nat. Commun."},{"key":"74412_CR33","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41375-024-02303-w","volume":"38","author":"A Ismael","year":"2024","unstructured":"Ismael, A. et al. CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma. Leukemia 38, 1777\u20131786 (2024).","journal-title":"Leukemia"},{"key":"74412_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neuint.2018.05.005","volume":"118","author":"HY Jung","year":"2018","unstructured":"Jung, H. Y. et al. Phosphatidylethanolamine-binding protein 1 protects CA1 neurons against ischemic damage via ERK-CREB signaling in Mongolian gerbils. Neurochem. Int. 118, 265\u2013274 (2018).","journal-title":"Neurochem. Int."},{"key":"74412_CR35","doi-asserted-by":"crossref","unstructured":"Yamamoto, Y. et al. Lysophosphatidylethanolamine affects lipid accumulation and metabolism in a human liver-derived cell line. Nutrients 14, 579 (2022).","DOI":"10.3390\/nu14030579"},{"key":"74412_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2023.08.029","volume":"80","author":"E Kaffe","year":"2024","unstructured":"Kaffe, E. et al. Bioactive signalling lipids as drivers of chronic liver diseases. J. Hepatol. 80, 140\u2013154 (2024).","journal-title":"J. Hepatol."},{"key":"74412_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/dbi20-0006","volume":"70","author":"A Cui","year":"2021","unstructured":"Cui, A., Ding, D. & Li, Y. Regulation of hepatic metabolism and cell growth by the ATF\/CREB family of transcription factors. Diabetes 70, 653\u2013664 (2021).","journal-title":"Diabetes"},{"key":"74412_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27533-9","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB\/CRTC2 transcriptional complex. Nat. Commun. 13, 246 (2022).","journal-title":"Nat. Commun."},{"key":"74412_CR39","doi-asserted-by":"publisher","first-page":"108411","DOI":"10.1016\/j.intimp.2021.108411","volume":"102","author":"J Hao","year":"2022","unstructured":"Hao, J., Sun, W. & Xu, H. Pathogenesis of concanavalin A induced autoimmune hepatitis in mice. Int. Immunopharmacol. 102, 108411 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"74412_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","volume":"66","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. The clinical phenotypes of autoimmune hepatitis: a comprehensive review. J. Autoimmun. 66, 98\u2013107 (2016).","journal-title":"J. Autoimmun."},{"key":"74412_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00281-018-0715-8","volume":"41","author":"D Schwinge","year":"2019","unstructured":"Schwinge, D. & Schramm, C. Sex-related factors in autoimmune liver diseases. Semin. Immunopathol. 41, 165\u2013175 (2019).","journal-title":"Semin. Immunopathol."},{"key":"74412_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","volume":"69","author":"Y Wei","year":"2020","unstructured":"Wei, Y. et al. Alterations of gut microbiome in autoimmune hepatitis. Gut 69, 569\u2013577 (2020).","journal-title":"Gut"},{"key":"74412_CR43","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/HEP.0000000000000506","volume":"80","author":"KM Schneider","year":"2024","unstructured":"Schneider, K. M., Kummen, M., Trivedi, P. J. & Hov, J. R. Role of microbiome in autoimmune liver diseases. Hepatology 80, 965\u2013987 (2024).","journal-title":"Hepatology"},{"key":"74412_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05589-3","volume":"14","author":"H Lin","year":"2023","unstructured":"Lin, H. et al. Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction. Cell Death Dis. 14, 68 (2023).","journal-title":"Cell Death Dis."},{"key":"74412_CR45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","volume":"67","author":"R Tang","year":"2018","unstructured":"Tang, R. et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 67, 534\u2013541 (2018).","journal-title":"Gut"},{"key":"74412_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fcimb.2020.00342","volume":"10","author":"J Lou","year":"2020","unstructured":"Lou, J. et al. Fecal microbiomes distinguish patients with autoimmune hepatitis from healthy individuals. Front. Cell Infect. Microbiol. 10, 342 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"74412_CR47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/apt.15754","volume":"51","author":"T Liwinski","year":"2020","unstructured":"Liwinski, T. et al. A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis. Aliment. Pharmacol. Ther. 51, 1417\u20131428 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"74412_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102652","volume":"52","author":"D Zou","year":"2020","unstructured":"Zou, D. et al. A SNP of bacterial blc disturbs gut lysophospholipid homeostasis and induces inflammation through epithelial barrier disruption. EBioMedicine 52, 102652 (2020).","journal-title":"EBioMedicine"},{"key":"74412_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.ampbs.2022.10.001","volume":"82","author":"X Cao","year":"2023","unstructured":"Cao, X., van Putten, J. P. M. & W\u00f6sten, M. Biological functions of bacterial lysophospholipids. Adv. Microb. Physiol. 82, 129\u2013154 (2023).","journal-title":"Adv. Microb. Physiol."},{"key":"74412_CR50","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/j.1572-0241.1998.1394a.x","volume":"93","author":"PL Bittencourt","year":"1998","unstructured":"Bittencourt, P. L. et al. Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2. Am. J. Gastroenterol. 93, 1394\u20131395 (1998).","journal-title":"Am. J. Gastroenterol."},{"key":"74412_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/hep.1840190311","volume":"19","author":"DG Doherty","year":"1994","unstructured":"Doherty, D. G. et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19, 609\u2013615 (1994).","journal-title":"Hepatology"},{"key":"74412_CR52","volume":"6","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1. JHEP Rep. Innov. Hepatol. 6, 100926 (2024).","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"74412_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S2468-1253(20)30328-9","volume":"6","author":"R Liberal","year":"2021","unstructured":"Liberal, R., de Boer, Y. S. & Heneghan, M. A. Established and novel therapeutic options for autoimmune hepatitis. Lancet Gastroenterol. Hepatol. 6, 315\u2013326 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"74412_CR54","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jhep.2023.11.032","volume":"80","author":"R Snijders","year":"2024","unstructured":"Snijders, R. et al. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis. J. Hepatol. 80, 576\u2013585 (2024).","journal-title":"J. Hepatol."},{"key":"74412_CR55","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s42255-025-01356-0","volume":"7","author":"S Jung","year":"2025","unstructured":"Jung, S. et al. Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis. Nat. Metab. 7, 1801\u20131818 (2025).","journal-title":"Nat. Metab."},{"key":"74412_CR56","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei, W. et al. Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid. Nat. Microbiol. 8, 1534\u20131548 (2023).","journal-title":"Nat. Microbiol."},{"key":"74412_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40553-x","volume":"14","author":"S Penumutchu","year":"2023","unstructured":"Penumutchu, S., Korry, B. J., Hewlett, K. & Belenky, P. Fiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potential. Nat. Commun. 14, 5161 (2023).","journal-title":"Nat. Commun."},{"key":"74412_CR58","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/s42255-024-01107-7","volume":"6","author":"PHV Saavedra","year":"2024","unstructured":"Saavedra, P. H. V. et al. Broad-spectrum antibiotics disrupt homeostatic efferocytosis. Nat. Metab. 6, 1682\u20131694 (2024).","journal-title":"Nat. Metab."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74412-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74412-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74412-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:03:19Z","timestamp":1785495799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74412-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74412"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74412-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7614"}}